These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34438996)

  • 21. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant
    El Ghali A; Stamper K; Kunz Coyne AJ; Holger D; Kebriaei R; Alexander J; Lehman SM; Rybak MJ
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0072823. PubMed ID: 37877697
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimizing in vitro phage-ciprofloxacin combination formulation for respiratory therapy of multi-drug resistant Pseudomonas aeruginosa infections.
    Hong Q; Chang RYK; Assafiri O; Morales S; Chan HK
    Int J Pharm; 2024 Mar; 652():123853. PubMed ID: 38280500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
    Yang M; Du C; Gong P; Xia F; Sun C; Feng X; Lei L; Song J; Zhang L; Wang B; Xiao F; Yan X; Cui Z; Li X; Gu J; Han W
    Res Microbiol; 2015 Oct; 166(8):633-43. PubMed ID: 26254772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.
    Secher T; Fas S; Fauconnier L; Mathieu M; Rutschi O; Ryffel B; Rudolf M
    PLoS One; 2013; 8(9):e73396. PubMed ID: 24023870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice.
    Chang RYK; Chow MYT; Wang Y; Liu C; Hong Q; Morales S; McLachlan AJ; Kutter E; Li J; Chan HK
    Clin Microbiol Infect; 2022 Jul; 28(7):983-989. PubMed ID: 35123053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
    Rossitto M; Fiscarelli EV; Rosati P
    Front Microbiol; 2018; 9():775. PubMed ID: 29780361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.
    Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL
    mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR)
    Vashisth M; Jaglan AB; Yashveer S; Sharma P; Bardajatya P; Virmani N; Bera BC; Vaid RK; Anand T
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
    Rees VE; Yadav R; Rogers KE; Bulitta JB; Wirth V; Oliver A; Boyce JD; Peleg AY; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Use of Phage and Antibiotics Therapy for the Eradication of Two Bacterial Pathogens from the Respiratory Tract of an Infant.
    Morozova VV; Kozlova YN; Tikunova NV
    Methods Mol Biol; 2024; 2734():237-243. PubMed ID: 38066373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Efficacy of Phage Therapy in a Murine Model of
    Yang X; Haque A; Matsuzaki S; Matsumoto T; Nakamura S
    Front Microbiol; 2021; 12():682255. PubMed ID: 34290683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topically applied bacteriophage to control multi-drug resistant
    Wang J; Meng W; Zhang K; Wang J; Lu B; Wang R; Jia K
    Front Microbiol; 2022; 13():1031101. PubMed ID: 36329839
    [No Abstract]   [Full Text] [Related]  

  • 39. Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of
    Martin I; Morales S; Alton EWFW; Davies JC
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant
    Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S
    Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.